X4 Pharmaceuticals Inc is a late-stage clinical biopharmaceutical company engaged in the research and development of novel therapeutics for the treatment of rare diseases and those with limited treatment options, with a focus on conditionsresulting from dysfunction of the immune system.
Ratings
0 / 5
0 ratings in the last 12 months
5
4
3
2
1
CEO
Dr. Paula S. Ragan$216.6M
Market Cap • 24/04/20242010
(há 14 anos)
2017
(7 years ago)
NASDAQ
Listagem
Boston
Sede • Massachusetts70
N° de Empregados • 2022Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
XFORSó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.